Purdue Pharma sentencing begins

The legal reckoning for the maker of OxyContin has reached a critical turning point as a judge prepares to deliver the final sentence.

Purdue Pharma pleaded guilty to criminal charges related to its aggressive marketing of the highly addictive painkiller, which fueled a nationwide epidemic of overdose deaths.

The sentencing will finalize the company's dissolution and the transfer of its assets to a public benefit corporation.

Victims and their families have been given the opportunity to provide impact statements, many calling for more severe personal consequences for the company's former executives.